Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Purpose There is a growing body of evidence suggesting a decisive involvement of the human lipid metabolism in cancer development. However, clinical data on the association between blood triglyceride or cholesterol levels including the cholesterol transporters high-density and low-density lipoproteins (LDL, HDL) and cancer incidence have remained inconclusive. Here, we investigated the association between blood triglyceride as well as total, LDL and HDL cholesterol levels and cancer among outpatients from Germany. Methods 61,936 patients with available blood lipid values were identified from the IQVIA Disease Analyzer database and followed up between 2005 and 2019. Multivariable logistic regression models were used to study the association between lipid values and cancer. Results The probability of cancer was significantly lower among patients with elevated total cholesterol concentrations and higher in patients with decreased HDL serum levels. In contrast, serum concentrations of LDL and triglycerides had no impact on cancer risk. In cancer site-stratified analyses, we observed a trend towards higher rates of cancers from digestive organs, breast, skin cancer, urinary tract and cancers from lymphoid and hematopoietic tissue in patients with HDL values < 35 mg/dl, while a negative association between total cholesterol > 250 mg/dl and respiratory organ as well as urinary tract cancers was observed. Conclusion Our data strongly support the hypothesis that serum-specific lipid profiles are positively associated with cancer.

Treating COVID-19 with Anticoagulation Based on Kabir Bleeding Risk Score

Three large randomized clinical trials named the ATTACC, ACTIV-4a, and REMAP-CAP were terminated early as these trials showed use of therapeutic anticoagulation among non-critical COVID-19 patients increased the probability of survival to hospital discharge as well as reduced the need for cardiovascular or respiratory organ support. These clinical trials also showed when a COVID-19 patient presents with a critical stage, therapeutic anticoagulation does not provide any benefit. This study retrospectively evaluated the COVID-19 admission at Jackson Hospital, Alabama, USA from June 15th, 2020, to June 15th, 2021. The study developed COVID-19 mechanism of death and found that anticoagulation doses can be titrated up or down based on D-Dimer trends and many patients do not need therapeutic anticoagulation, rather an intermediate dose (Lovenox 0.5mg/kg subQ BID or higher dose) anticoagulation can be sufficient for those who have a higher risk of bleeding. The author developed the Kabir bleeding risk score-based treatment strategies for COVID-19 patients which can be visited by clicking on the following link: .

Treating COVID-19 with Anticoagulation Based on Kabir Bleeding Risk Score

Three large randomized clinical trials named the ATTACC, ACTIV-4a, and REMAP-CAP were terminated early as these trials showed use of therapeutic anticoagulation among non-critical COVID-19 patients increased the probability of survival to hospital discharge as well as reduced the need for cardiovascular or respiratory organ support. These clinical trials also showed when a COVID-19 patient presents with a critical stage, therapeutic anticoagulation does not provide any benefit. This study retrospectively evaluated the COVID-19 admission at Jackson Hospital, Alabama, USA from June 15th, 2020, to June 15th, 2021. The study developed COVID-19 mechanism of death and found that anticoagulation doses can be titrated up or down based on D-Dimer trends and many patients do not need therapeutic anticoagulation, rather an intermediate dose (Lovenox 0.5mg/kg subQ BID or higher dose) anticoagulation can be sufficient for those who have a higher risk of bleeding. The author developed the Kabir bleeding risk score-based treatment strategies for COVID-19 patients which can be visited by clicking on the following link: .

A CASE STUDY ON REDUCTION OF LUNG FUNCTIONS IN PATIENTS WITH DIABETES MELLITUS IN ANDHRA PRADESH, INDIA

Background and Objectives: The purpose of this study is to evaluate the pulmonary functions in patients with diabetes. Many studies additionally counsel that the respiratory organ as an organ in diabetes and glycemic exposure could also be an effort issue for reduced respiratory organ operate. Systemic inflammation, hypoxemia, oxidative stress, altered gas exchange, and changes in lung tissues were the major impacts on the respiratory system which were induced by hypoglycemia. Methods: Forty individual patients of both sexes were involved in the study and divided into two groups depending on their conditions. Group A consists of individuals without any complications or any disease conditions and group B consists of diabetic patients excluding smokers and divided into twenty to each group. Results: SPSS software was used for the analysis and spirometry was the device used to determine the pulmonary function. Values of Forced Expiratory Volume 1, Forced Vital Capacity, Forced Expiratory Flow, FEV% were only considered in the study and the study results conclude that diabetes shows its effect on the lungs in long term and leads to a decrease in lung function. Conclusion: It was concluded that that monitoring the Pulmonary function tests of the diabetic patients helps the individuals to avoid any complications further ahead and also it helps to ease the flow of the recovery and also prevent further more comorbidity that might arise in the future. Peer Review History: Received: 1 September 2021; Revised: 10 October; Accepted: 4 October, Available online: 15 November 2021 Academic Editor: Dr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, [email protected] UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file: Reviewer's Comments: Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewers: Kolawole Oyetunji Timothy, Department of Pharmacology and Therapeutics, Ladoke Akintola University of Technology, Ogbomoso, Nigeria. [email protected] Dr. Nuray Arı, Ankara University, Turkiye, [email protected] Rima Benatoui, Laboratory of Applied Neuroendocrinology, Department of Biology, Faculty of Science, Badji Mokhtar University Annaba, BP12 E L Hadjar–Algeria, [email protected] Similar Articles: CLINICAL COURSE AND DISEASE OUTCOME IN COVID-19 PATIENTS WITH DIABETES MELLITUS THE RELATIONSHIP BETWEEN DIABETES MELLITUS AND TUBERCULOSIS IN REVIEW OF PREVALENCE, DIAGNOSTICS AND PREVENTION

The larynx

The larynx, trachea and bronchi develop embryologically from the foregut in the form of an outpouching during the fourth week of gestation. The larynx bridges the gap from the base of the tongue above, to the trachea below lying within the hypopharynx. It sits in the neck spanning the distance from the third to sixth cervical vertebrae. It is a complex respiratory organ composed of a cartilage framework, ligaments, intrinsic and extrinsic muscles and is lined by an epithelial mucous membrane continuous above with the pharynx and below with the trachea. Its primary function is protection of the lower respiratory tract against aspiration. It allows the generation of a high intrathoracic pressure required for coughing, straining and lifting (Valsalva manoeuvre) and phonation. The anatomy of the larynx can either be considered by its surgical division of the supraglottis, glottis and subglottis (these landmarks are important in the consideration of cancer spread).

Terapi Jalā Netī sebagai Upaya Pembersihan Saluran Pernapasan Hidung

<p><em>The nose is a vital respiratory organ that has a role as the first organ that protects the body in the respiratory tract against microorganisms and other harmful substances that are inhaled along with the entry of air. Therefore, nasal hygiene is something that needs to be considered, especially if there are disturbances. One way that can be done is by means of Jalā Netī therapy. Jalā Netī therapy or nasal cleansing is a simple technique that can be used to treat symptoms of problems or diseases that occur in the nasal cavity. Jalā Netī therapy or nasal cleansing has benefits if done properly. Jalā Netī is part of the six body cleansing techniques in Hatha Yoga called Shatkarmā. There are four main texts of Hatha Yoga that describe Jalā Netī including Hatha Yoga Pradipika, Gheranda Samhita, Shiva Samhita and Hatharatnavali. Jalā Netī is performed by flowing warm water mixed with a little salt (Lavan Jalā) from one nostril to the other using a specially designed pot or tool. Jalā Netī has a cleansing effect on the nasal cavity by removing the remaining dirt and microorganisms in the nasal cavity and providing healing therapy for disorders or diseases of the nasal respiratory tract.</em></p>

Treating COVID-19 with Anticoagulation based on Kabir Bleeding Risk Score

Three large randomized clinical trials named the ATTACC, ACTIV-4a, and REMAP-CAP were terminated early as these trials showed use of therapeutic anticoagulation among non-critical COVID-19 patients increased the probability of survival to hospital discharge as well as reduced the need for cardiovascular or respiratory organ support. These clinical trials also showed when a COVID-19 patient presents with a critical stage, therapeutic anticoagulation does not provide any benefit. The authors also had approx. two thousand five hundred COVID-19 encounters and found that anticoagulation doses can be titrated up or down based on D-Dimer trends and many patients do not need therapeutic anticoagulation, rather an intermediate dose (Lovenox 0.5mg/kg subQ BID or equivalent) anticoagulation can be sufficient for those who have a higher risk of bleeding. The author developed the Kabir bleeding risk score-based treatment strategies for COVID-19 patients which can be visited by clicking on the following link: .

Prevalence of Anti-Phospholipid Autoantibodies and Their Association with Respiratory SOFA Component in Patients with COVID-19 Pneumonia: A Prospective Cohort Analysis in Tunisia

Purpose: The aim of our study was to evaluate the prevalence of aPLAs among Tunisian critically-ill covid19 and non-covid19 patients and to investigate the clinical significance of aPLAs by determining the SOFA score and their respiratory failure during their ICU stay. Methods: We conducted a prospective observational cohort study including critically ill COVID-19 patients and non-COVID-19 patients with pulmonary origin sepsis, admitted to the intensive care unit. Blood samples were collected on days 1, 3, 5, 8 and 10 of hospitalization in order to measure titers of anti-cardiolipin (aCL), anti-phosphatidylserine (aPS) by chemiluminescence immunoassay. Results: We enrolled 43 COVID-19 patients and 31 non COVID-19 with pulmonary origin sepsis. In-hospital mortality rate was significantly higher (p=0.026) in COVID-19 patients (79%). 58.8% of COVID-19 patients were aPLA positive; however, only 22.5% of the non-COVID-19 were positive for aPLA (p=0.002). A significant positive correlation existed between respiratory SOFA component at days 3, 5, 8 and 10 and anti-phospholipid antibodies concentrations. Conclusion: Based on our results, for the first time, anti-phospholipid antibodies may be used as an independent indicator of respiratory organ failure in critically ill patients, to stratify and assess the prognosis of pulmonary origin sepsis and COVID-19.

A CLINICAL CASE OF PROGRESSIVE COURSE OF SARCOIDOSIS OF THE RESPIRATORY ORGANS

Sarcoidosis is a systemic inflammatory disease of unknown etiology, characterized by the formation of noncaseating granulomas and multiple system organ damage. Sarcoidosis therapy is aimed at prevention and reducing inflammation as well as improving patient’s symptoms and quality of life. Active observation is preferred for patients with morphologically confirmed diagnosis in the absence of a lifethreatening condition, organ and system dysfunction as well as disease progression. Alternative therapy may include alphatocopherol and/or pentoxifylline. Treatment with glucocorticosteroids is used for a long period of time (12-24 months) only when clinically indicated. The presented clinical case of progressive course of respiratory organ sarcoidosis is intended to draw the attention of doctors to the peculiarities of examination, treatment and observation of such patients. The case is discussed from the perspective of personalized medicine and modern clinical guidelines.